Loading clinical trials...
Loading clinical trials...
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Conditions
Interventions
GP0112
Restylane Lyft Lidocaine
Locations
15
Canada
Galderma Research Site
Calgary, Alberta, Canada
Galderma Research Site
Edmonton, Alberta, Canada
Galderma Research Site
Edmonton, Alberta, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Start Date
May 2, 2022
Primary Completion Date
January 17, 2023
Completion Date
March 5, 2024
Last Updated
April 9, 2024
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions